Previous 10 | Next 10 |
Initiated four Phase 2 clinical studies based on compelling prior data Actions taken on ongoing clinical studies due to COVID-19 pandemic Strong cash position following recently completed common stock offering provides runway into 2022 Conference call today at 5:00 p.m. EDT ...
EVANSTON, Ill., March 18, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced that the company will host a conference call and live ...
Sintx Technologies (NASDAQ: SINT ) +74% on agreement toward establishing a collaboration framework with Nissin Manufacturing. More news on: Sintx Technologies, Inc., Riot Blockchain, Inc., MYOS RENS Technology Inc., Stocks on the move, , Read more ...
Thinly traded micro cap Aptinyx (NASDAQ: APTX ) perks up 8% premarket on light volume in reaction to the publication of preclinical data on NYX-458 in the journal Movement Disorders. More news on: Aptinyx Inc., Healthcare stocks news, Stocks on the move, Read more ... ...
EVANSTON, Ill., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced a publication in Movement Disorders detailing d...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Shares of Aptinyx (NASDAQ: APTX) , a clinical-stage biotech focused on the brain and nervous system, rose about 27% on Friday. The double-digit jump appears to be linked to the filing of an SEC document that shows that Adams Street Partners -- an investment management company with $40 b...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Are These 5 Companies On Your List Of Penny Stocks Right Now? There’s no doubt that penny stocks are best known for volatility. No matter how you look at it, the general feeling about these cheap stocks is speculative in nature. However, one thing you shouldn’t do as a trader i...
Gainers: Seneca Biopharma (NASDAQ: SNCA ) +126% . More news on: Seneca Biopharma, Inc., iMedia Brands, Inc., Aptinyx Inc., Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Signature Bank (SBNY) is expected to report for Q3 2023 BHP Group Ltd. (BHP) is expected to report for Q1 2024 Sorrento Therapeutics Inc. (SRNEQ) is expected to report $-0.15 for Q3 2023 Baran Group Ltd. (BRANF) is expected to report for quarter end 2023-09-30 World Copper (WCUFF)...
GLG Life Tech Corporation (GLGLF) is expected to report for Q1 2024 Accenture plc Class A (Ireland) (ACN) is expected to report $3.14 for Q1 2024 Greenlane Holdings Inc. (GNLN) is expected to report $-2.7 for Q3 2023 iMedia Brands Inc. (IMBIQ) is expected to report for quarter end 202...
Axcella Health Inc. (AXLA) is expected to report for Q3 2023 Telekom Malaysia Bhd (MYTEF) is expected to report for quarter end 2023-09-30 Atento S.A. (ATTOF) is expected to report for Q3 2023 Scryb Inc Com (SCYRF) is expected to report for Q4 2023 BHP Group Ltd. (BHP) is expected...